Lee Jaekyoung, Bang Seung Pil, Kim Jae-Gon, Jun Jong Hwa
Department of Ophthalmology, Keimyung University School of Medicine, 1035 Dalgubeol-daero, Dalseo-gu, Daegu, 42601, Republic of Korea.
Sci Rep. 2025 Jul 28;15(1):27459. doi: 10.1038/s41598-025-93764-1.
Tear hyperosmolarity plays a crucial role in initiation of inflammatory response and damage to ocular surface epithelia. Accurate measurement of tear osmolarity is essential for dry eye. This prospective observational and experimental study was conducted in 182 eyes of 182 participants, including 115 subjects with dry eye (Sjögren syndrome aqueous-deficient dry eye [SS ADDE], non-SS ADDE, and evaporative DE [EDE]), 36 with conjunctivochalasis (CCh), and 31 normal controls (NC). The ocular surface disease index (OSDI), tear meniscus height (TMH), Schirmer I test, tear matrix metalloproteinase-9 (MMP-9), tear breakup time, and ocular staining score were assessed. Tear osmolarity was measured using the TearLab osmolarity system (Escondido, CA, USA) by applying 1.0 μl tears collected by micropipette to the TearLab test card or by direct contact between the test card and the temporal tear meniscus. For in vitro analyses, osmolarity of 271.25, 300, 347.5, and 395 mOsm/L solutions were measured at various volumes (0.2, 0.5, 1.0, 2.0, and 5.0 μl) with a TearLab osmometer. Tear osmolarity measured by direct contact was higher than that measured by micropipette (13.7 ± 10.5 mOsm/L, p < 0.001). The difference of osmolarities was higher in the non-SS ADDE, SS ADDE, and CCh than in the NC and EDE (p < 0.001 for all). Osmolarity was negatively correlated with Schirmer score and TMH (r = - 0.346, p < 0.001; r = - 0.447, p < 0.001, respectively). The smaller the sample volume, the higher the measured osmolarity in the in vitro analysis at 300 and 347.5 mOsm/L (r = - 0.659, p < 0.01; r = - 0.579, p < 0.05, respectively). The TearLab osmometer tended to report higher tear osmolarity inversely proportional to sample volumes, possibly due to the evaporation effect. Therefore, care should be taken when interpreting tear osmolarity in patients with low tear volume or CCh.
泪液高渗在引发炎症反应和损伤眼表上皮细胞过程中起着关键作用。准确测量泪液渗透压对干眼症至关重要。本前瞻性观察性和实验性研究纳入了182名参与者的182只眼睛,其中包括115名干眼症患者(干燥综合征性泪液缺乏型干眼症[SS ADDE]、非SS ADDE和蒸发过强型干眼症[EDE])、36名结膜松弛症(CCh)患者以及31名正常对照者(NC)。评估了眼表疾病指数(OSDI)、泪河高度(TMH)、Schirmer I试验、泪液基质金属蛋白酶-9(MMP-9)、泪膜破裂时间和眼表染色评分。使用TearLab渗透压系统(美国加利福尼亚州埃斯孔迪多)测量泪液渗透压,方法是将微量移液器收集的1.0 μl眼泪滴加到TearLab测试卡上,或使测试卡直接接触颞侧泪河。对于体外分析,使用TearLab渗透压计在不同体积(0.2、0.5、1.0、2.0和5.0 μl)下测量271.25、300、347.5和395 mOsm/L溶液的渗透压。直接接触法测得的泪液渗透压高于微量移液器法(13.7±10.5 mOsm/L,p<0.001)。非SS ADDE、SS ADDE和CCh患者泪液渗透压的差异高于NC和EDE患者(所有p<0.001)。渗透压与Schirmer评分和TMH呈负相关(r=-0.346,p<0.001;r=-0.447,p<0.001)。在体外分析中,300和347.5 mOsm/L时,样本体积越小,测得的渗透压越高(r=-0.659,p<0.01;r=-0.579,p<0.05)。TearLab渗透压计测得的泪液渗透压往往与样本体积成反比,报告值较高,这可能是由于蒸发效应。因此,在解读泪液量少或患有结膜松弛症患者的泪液渗透压时应谨慎。